PHI with Labial fusion
How does this condition affect your private health insurance?
Verschmelzung der Labien, also known as labial fusion or synechia vulvae, is a condition predominantly observed in prepubertal girls. It involves the partial or complete adherence of the labia minora, often resulting from low estrogen levels combined with local irritation or inflammation. While frequently asymptomatic and discovered incidentally, it can lead to symptoms such as urinary dribbling, recurrent urinary tract infections (UTIs) due to urine pooling, or local discomfort. Diagnosis relies on a physical examination. Most cases resolve spontaneously, typically around puberty with rising estrogen levels. Symptomatic treatment usually involves topical estrogen cream, or less commonly, gentle manual separation or surgical intervention.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to years if untreated; days to weeks with treatment.
Duration of Illness (Lifetime)
One-time event in childhood, rarely recurs after puberty or successful treatment.
Cost of Treatment (Initial)
Low (e.g., costs of topical medication) to moderate (e.g., minor outpatient surgical procedure).
Cost of Treatment (Lifetime)
Generally low to moderate, similar to first occurrence, as recurrence is infrequent.
Mortality Rate
Negligible (effectively 0%).
Risk of Secondary Damages
Low. Potential for recurrent urinary tract infections (UTIs), local irritation, or, rarely, psychological distress if prolonged and symptomatic.
Probability of Full Recovery
Very high (>95%) with or without intervention, especially after puberty or appropriate treatment.
Underlying Disease Risk
Very low. Not typically associated with serious underlying systemic diseases; sometimes linked to local irritation or hygiene issues.